Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.55B 4.1B 523M 457M 422M 394M 742M 49.42B 755M 5.07B 1.97B 24.38B 1.96B 1.92B 84.95B P/E 2026 *
7.81x
P/E 2027 * 6.93x
Enterprise Value 3.55B 4.1B 523M 457M 422M 394M 742M 49.42B 755M 5.07B 1.97B 24.38B 1.96B 1.92B 84.95B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.47x
Free-Float
45.7%
Yield 2026 *
5.77%
Yield 2027 * 6.49%
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
11-28 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective November 28, 2025 CI
11-28 Tong Ren Tang Technologies Co., Ltd. Enters into Supplemental Trademark Framework Agreement with Tong Ren Tang Holdings CI
1 day-0.93%
1 week-0.31%
Current month-9.09%
1 month-9.09%
3 months-20.40%
6 months-27.11%
Current year-27.44%
1 week 3.07
Extreme 3.07
3.33
1 month 3.07
Extreme 3.07
3.67
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.52
3 years 3.07
Extreme 3.07
7.8
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Compliance Officer 47 28/11/2025
Comptroller/Controller/Auditor 48 04/06/2025
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-0.31%-35.74%-56.87% 527M
-2.39%-2.65%-15.23%-9.43% 12.74B
-1.87%-1.87%-36.84%-58.96% 4.75B
-0.96%+0.13%-13.70%-15.40% 4.33B
-3.47%-0.33%+6.99%-40.94% 3.82B
-1.98%-1.51%+11.67%-18.14% 3.75B
-15.92%-13.79%-23.40%-23.32% 3.58B
-3.29%-3.36%-15.62%-8.06% 3.01B
-4.01%-3.38%-9.65%-28.88% 2.36B
-2.66%-2.76%-14.59%+21.66% 1.65B
Average -3.75%-2.92%-14.61%-23.84% 4.05B
Weighted average by Cap. -3.59%-2.46%-13.68%-21.27%

Financials

2026 *2027 *
Net sales 6.98B 8.06B 1.03B 900M 831M 775M 1.46B 97.19B 1.49B 9.96B 3.87B 47.96B 3.86B 3.78B 167B 7.56B 8.73B 1.11B 975M 900M 839M 1.58B 105B 1.61B 10.79B 4.19B 51.95B 4.18B 4.09B 181B
Net income 454M 525M 66.91M 58.57M 54.06M 50.43M 95.02M 6.33B 96.72M 648M 252M 3.12B 251M 246M 10.88B 514M 593M 75.59M 66.17M 61.08M 56.98M 107M 7.15B 109M 733M 284M 3.53B 284M 278M 12.29B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
30/06/26 HK$3.200 -0.93% 537,000
29/06/26 HK$3.230 +3.19% 1,229,000
26/06/26 HK$3.130 -0.95% 1,389,000
25/06/26 HK$3.160 -0.94% 1,314,000
24/06/26 HK$3.190 -3.63% 1,382,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.772CNY
Average target price
4.601CNY
Spread / Average Target
+65.99%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock